By species
🐈Cats
More than 50% of domestic cats are overweight/obese — and weight reduction is among the few interventions shown to extend feline lifespan.
Common conditions where peptides are studied
Overweight/obesity
Diabetes mellitus
Chronic kidney disease
Geriatric immune support
Relevant peptides
Standard-of-care
Insulin
Replaces or supplements endogenous insulin to control blood glucose.
View monograph In clinical trialsGLP-1 receptor agonists (Exenatide / OKV-119)
Reduces appetite and improves glucose handling — the same biology behind human GLP-1 weight-loss drugs.
View monograph InvestigationalSS-31 (Elamipretide)
Targets the inner mitochondrial membrane to support energy production — under interest for chronic kidney disease.
View monograph